DG3 Stock Chart & Stats
€39.04
€0.00(0.00%)
At close: 4:00 PM EDT
€39.04
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€30.86 - €58.68
Previous CloseN/A
Volume0.00
Average Volume (3M)14.00
Market Cap
€4.26B
Enterprise Value€18.80K
Total Cash (Recent Filing)€1.76B
Total Debt (Recent Filing)€12.55B
Price to Earnings (P/E)―
Beta1.20
Next Earnings
Aug 04, 2026EPS Estimate
1.96Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.00
Shares Outstanding109,662,540
10 Day Avg. Volume16
30 Day Avg. Volume14
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)1.14
Price to Sales (P/S)0.49
P/FCF Ratio5.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€56.82Price Target Upside45.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
EPS Forecast (FY)5.32
Revenue Forecast (FY)€8.77B
Bulls Say, Bears Say
Bulls Say
Positive Free Cash Flow TrendSustained positive operating and free cash flow provides a durable liquidity cushion to fund operations, capex, dividends and debt service even while earnings recover. This cash generation reduces short‑term refinancing pressure and supports strategic flexibility through cycles.
Engineered Materials Margin ExpansionA structurally higher margin profile in Engineered Materials signals stronger pricing power and product differentiation. Higher, repeatable EM margins support resilient EBITDA generation, improve cash conversion potential over time, and insulate the company from commodity acetyl volatility.
Active Near‑term Debt ManagementProactively redeeming near‑maturity notes reduces refinancing risk and clarifies the near‑term maturity schedule. This action improves financing flexibility and signals management focus on balance‑sheet stability, important given existing leverage while earnings normalize.
Bears Say
Elevated LeverageDebt at approximately 3x equity materially constrains financial flexibility, raising interest and covenant risk if earnings remain weak. High leverage amplifies downside in cyclical end markets, limits M&A or investment optionality, and makes recovery dependent on rapid earnings improvement.
Sharp Revenue Decline And LossesA large, persistent revenue decline and current losses erode returns and equity, reducing internal funding ability. This weak top‑line and margin compression increase dependence on cost programs and cash conversion to service obligations and may lengthen the timeline to sustained profitability.
Operational Headwinds: Turnarounds & DisruptionsPlanned turnarounds, feedstock outages and absorption hits reduce volumes and inflate per‑unit fixed costs, depressing margins and deferring cash realization. These recurring operational disruptions make near‑term earnings and cash conversion lumpy and complicate planning for deleveraging.
Celanese News
DG3 FAQ
What was Celanese Corp’s price range in the past 12 months?
Celanese Corp lowest stock price was €30.86 and its highest was €58.68 in the past 12 months.
What is Celanese Corp’s market cap?
Celanese Corp’s market cap is €4.26B.
When is Celanese Corp’s upcoming earnings report date?
Celanese Corp’s upcoming earnings report date is Aug 04, 2026 which is in 3 days.
How were Celanese Corp’s earnings last quarter?
Celanese Corp released its earnings results on May 05, 2026. The company reported €0.747 earnings per share for the quarter, missing the consensus estimate of €0.783 by -€0.036.
Is Celanese Corp overvalued?
According to Wall Street analysts Celanese Corp’s price is currently Undervalued.
Does Celanese Corp pay dividends?
Celanese Corp does not currently pay dividends.
What is Celanese Corp’s EPS estimate?
Celanese Corp’s EPS estimate is 1.96.
How many shares outstanding does Celanese Corp have?
Celanese Corp has 109,662,540 shares outstanding.
What happened to Celanese Corp’s price movement after its last earnings report?
Celanese Corp reported an EPS of €0.747 in its last earnings report, missing expectations of €0.783. Following the earnings report the stock price went down -0.068%.
Which hedge fund is a major shareholder of Celanese Corp?
Currently, no hedge funds are holding shares in DE:DG3
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Celanese Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€56.82 (45.55% Upside)
€56.82 (45.55% Upside)
Blogger Sentiment
Bullish
DE:DG3 Sentiment 80%
Sector Average 69%
Sector Average 69%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.19%
12-Months-Change
Fundamentals
Return on Equity
0.28%
Trailing 12-Months
Asset Growth
-6.30%
Trailing 12-Months
Company Description
Celanese Corp
Celanese Corporation produces and sells engineered polymers worldwide. It operates through Engineered Materials and Acetyl Chain segments. The company offers ethylene acrylic elastomers, ethylene vinyl acetate pharmaceutical grade copolymers, liquid crystal polymers, long-fiber reinforced thermoplastics, nylon and polypropylene compounds and formulations, polyoxymethylene, ultra-high molecular weight polyethylene, and thermoplastic elastomers, polyesters, and vulcanizates for use in appliance, automotive, construction, consumer apparel, consumer electronics, electrical, energy storage, filtration equipment, industrial, medical, and telecommunication applications. It also provides acetic acid and anhydride, acetate flakes and tows, butyl acetates, emulsion polymers, ethyl acetates, ethylene vinyl acetate resins and compounds, formaldehydes, redispersible powders, and vinyl acetate monomers for use in adhesives, automotive parts, coatings, consumer goods, external thermal insulation composite systems, films, filtration, flexible packaging, food and beverage, food packaging, inks, lamination, lubricants, paints, paper finishing, pharmaceuticals, plasticizers, plasters and renders, solvents, textiles, and tiling applications. The company offers its products under the Amcel, AOPlus, Ateva, Avicor, Celanese, Celanex, Celanyl, Celcon, Celstran, Celvolit, Clarifoil, Crastin, Dur-O-Set, Dytron, ECOMID, EcoVAE, Elotex, Factor, Flexbond, Forprene, FRIANYL, Fortron, Geolast, GHR, GUR, Hostaform, Hytrel, Laprene, Melinex, MetaLX, Mowilith, MT, Mylar, NILAMID, Nylfor, OmniLon, Pibifor, Pibiter, Polifor, Resyn, Rynite, Santoprene, SlideX, Sofprene, Sofpur, Talcoprene, Tarnoform, Tecnoprene, TufCOR, Tynex, Vamac, VAntage, Vectra, Vinac, Vinamul, VitalDose, Zenite, and Zytel brands. It sells its products directly to customers and through distributors; and original equipment manufacturers and suppliers. Celanese Corporation was founded in 1912 and is headquartered in Irving, Texas.
DG3 Company Deck
DG3 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call was cautiously optimistic: management provided a constructive back‑half EPS target (~$3) and highlighted several operational strengths — a sizable expected Q2 improvement in the acetyl chain, EM margin progress (now north of 20%), targeted $30M in nylon savings, Clear Lake’s high utilization and global network flexibility, and price pass-through beginning to flow into P&L. However, the company also flagged meaningful near‑term headwinds: weak end‑market demand, supply‑chain and shipping disruptions (including benzene asset outages), regional pricing volatility (China), planned turnarounds and absorption hits (Q2 and H2), and working capital timing that will defer some cash conversion. Overall, the positives (guidance, margin improvement, targeted cost savings and operational flexibility) modestly outweigh the near‑term risks and uncertainties.View all DE:DG3 earnings summariesDG3 Net sales Breakdown
56.48% Engineered Materials
44.34% Acetyl Chain
-0.82% Eliminations
DG3 Stock 12 Month Forecast
Average Price Target
€56.82
▲(45.55% Upside)